SEC 13F Intelligence

Reynders Mcveigh Capital Management, LLC / VRTX

Reynders Mcveigh Capital Management, LLC’s Vertex Pharmaceuticals Inc Position

Does Reynders Mcveigh Capital Management, LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 54.7K shares worth $24M (+1.23% of its 13F portfolio) as of Q1 2026, up from 53.9K shares the prior filed quarter.

Position Value
$24M
Q1 2026
Shares
54.7K
% of Portfolio
+1.23%
Quarters Held
8
currently held

Position History VRTX

Reported value by quarter
Q1 ’24: $13MQ1 ’24Q2 ’24: $20MQ2 ’24Q3 ’24: $23MQ3 ’24Q4 ’24: $21MQ4 ’24Q1 ’25: $26MQ1 ’25Q3 ’25: $22MQ3 ’25Q4 ’25: $24MQ4 ’25Q1 ’26: $24MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202654.7K$24M+1.23%
Q4 202553.9K$24M+1.15%
Q3 202555.4K$22M+1.02%
Q1 202553.3K$26M+1.44%
Q4 202452.3K$21M+1.11%
Q3 202448.7K$23M+1.20%
Q2 202442.5K$20M+1.13%
Q1 202430.6K$13M+0.74%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Reynders Mcveigh Capital Management, LLC’s full portfolio or all institutional holders of VRTX.